{"pmid":32407609,"title":"De Novo Status Epilepticus in patients with COVID-19.","text":["De Novo Status Epilepticus in patients with COVID-19.","Neurological complications are increasingly recognized with SARS CoV-2, the causative pathogen for COVID-19. We present a single-center retrospective case series reporting the EEG and outcome of de novo status epilepticus (SE) in two African-American women with laboratory-confirmed SARS CoV-2 virus. SE was the initial presentation in one asymptomatic individual. Patient 2 had COVID-19 pneumonia, and fluctuating mental status that raised the suspicion of subclinical SE. The patient with older age and higher comorbidities failed to recover from the viral illness that has no definitive treatment.","Ann Clin Transl Neurol","Somani, Sana","Pati, Sandipan","Gaston, Tyler","Chitlangia, Alissa","Agnihotri, Shruti","32407609"],"abstract":["Neurological complications are increasingly recognized with SARS CoV-2, the causative pathogen for COVID-19. We present a single-center retrospective case series reporting the EEG and outcome of de novo status epilepticus (SE) in two African-American women with laboratory-confirmed SARS CoV-2 virus. SE was the initial presentation in one asymptomatic individual. Patient 2 had COVID-19 pneumonia, and fluctuating mental status that raised the suspicion of subclinical SE. The patient with older age and higher comorbidities failed to recover from the viral illness that has no definitive treatment."],"journal":"Ann Clin Transl Neurol","authors":["Somani, Sana","Pati, Sandipan","Gaston, Tyler","Chitlangia, Alissa","Agnihotri, Shruti"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32407609","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/acn3.51071","locations":["African-American"],"topics":["Case Report"],"weight":1,"_version_":1666802845272244224,"score":9.490897,"similar":[{"pmid":32344366,"pmcid":"PMC7172719","title":"Focal status epilepticus as unique clinical feature of COVID-19: A case report.","text":["Focal status epilepticus as unique clinical feature of COVID-19: A case report.","SARS-CoV-2, a novel zoonotic coronavirus, is currently spreading all over the world, causing a pandemic disease defined coronavirus disease 2019 (COVID-19). The spectrum of COVID-19 ranges from asymptomatic or mild infection to rapidly progressive, acute respiratory distress syndrome and death [1].To the best of our knowledge, status epilepticus has never been described as initial presentation of COVID-19. We report a patient affected by COVID-19 whose primary presentation was a focal status epilepticus.","Seizure","Vollono, Catello","Rollo, Eleonora","Romozzi, Marina","Frisullo, Giovanni","Servidei, Serenella","Borghetti, Alberto","Calabresi, Paolo","32344366"],"abstract":["SARS-CoV-2, a novel zoonotic coronavirus, is currently spreading all over the world, causing a pandemic disease defined coronavirus disease 2019 (COVID-19). The spectrum of COVID-19 ranges from asymptomatic or mild infection to rapidly progressive, acute respiratory distress syndrome and death [1].To the best of our knowledge, status epilepticus has never been described as initial presentation of COVID-19. We report a patient affected by COVID-19 whose primary presentation was a focal status epilepticus."],"journal":"Seizure","authors":["Vollono, Catello","Rollo, Eleonora","Romozzi, Marina","Frisullo, Giovanni","Servidei, Serenella","Borghetti, Alberto","Calabresi, Paolo"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32344366","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.seizure.2020.04.009","keywords":["covid-19","epilepsy","sars-cov-2","status epilepticus","viral infections"],"topics":["Case Report"],"weight":1,"_version_":1666138495769378816,"score":143.00214},{"pmid":32469627,"title":"Adaptation and evaluation of Turkish version of the fear of COVID-19 Scale.","text":["Adaptation and evaluation of Turkish version of the fear of COVID-19 Scale.","We investigated the psychometric properties of the Fear of COVID-19 Scale in Turkish among a diverse group with a focus on the prevalence of coronavirus related fear across gender, age intervals, SES, chronic illness situation, and educational level. Based on a confirmatory factor analysis, the Fear of COVID-19 Scale had appropriate psychometric properties for utilization, including excellent goodness-of-fit indices, a Cronbach's alpha value of .86, and discriminant validity, as shown by a significant negative correlation with resilience. Furthermore, group comparison analyses revealed that women reported significantly higher fear of coronavirus. Additionally, individuals from middle SES reported significantly higher fear of coronavirus while the fear of coronavirus did not differ based on participants' educational level, socioeconomic status, and age level. Implications for mental health providers are discussed.","Death Stud","Haktanir, Abdulkadir","Seki, Tolga","Dilmac, Bulent","32469627"],"abstract":["We investigated the psychometric properties of the Fear of COVID-19 Scale in Turkish among a diverse group with a focus on the prevalence of coronavirus related fear across gender, age intervals, SES, chronic illness situation, and educational level. Based on a confirmatory factor analysis, the Fear of COVID-19 Scale had appropriate psychometric properties for utilization, including excellent goodness-of-fit indices, a Cronbach's alpha value of .86, and discriminant validity, as shown by a significant negative correlation with resilience. Furthermore, group comparison analyses revealed that women reported significantly higher fear of coronavirus. Additionally, individuals from middle SES reported significantly higher fear of coronavirus while the fear of coronavirus did not differ based on participants' educational level, socioeconomic status, and age level. Implications for mental health providers are discussed."],"journal":"Death Stud","authors":["Haktanir, Abdulkadir","Seki, Tolga","Dilmac, Bulent"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32469627","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1080/07481187.2020.1773026","locations":["Turkish","Turkish"],"countries":["Turkey"],"countries_codes":["TUR|Turkey"],"weight":0,"_version_":1668167110036029441,"score":117.8279},{"pmid":32305181,"pmcid":"PMC7138149","title":"ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection.","text":["ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection.","The COVID-19 pandemics is posing unprecedented challenges and threats to patients and healthcare systems worldwide. Acute respiratory complications that require intensive care unit (ICU) management are a major cause of morbidity and mortality in COVID-19 patients. Patients with worst outcomes and higher mortality are reported to include immunocompromised subjects, namely older adults and polymorbid individuals and malnourished people in general. ICU stay, polymorbidity and older age are all commonly associated with high risk for malnutrition, representing per se a relevant risk factor for higher morbidity and mortality in chronic and acute disease. Also importantly, prolonged ICU stays are reported to be required for COVID-19 patients stabilization, and longer ICU stay may per se directly worsen or cause malnutrition, with severe loss of skeletal muscle mass and function which may lead to disability, poor quality of life and additional morbidity. Prevention, diagnosis and treatment of malnutrition should therefore be routinely included in the management of COVID-19 patients. In the current document, the European Society for Clinical Nutrition and Metabolism (ESPEN) aims at providing concise guidance for nutritional management of COVID-19 patients by proposing 10 practical recommendations. The practical guidance is focused to those in the ICU setting or in the presence of older age and polymorbidity, which are independently associated with malnutrition and its negative impact on patient survival.","Clin Nutr","Barazzoni, Rocco","Bischoff, Stephan C","Breda, Joao","Wickramasinghe, Kremlin","Krznaric, Zeljko","Nitzan, Dorit","Pirlich, Matthias","Singer, Pierre","32305181"],"abstract":["The COVID-19 pandemics is posing unprecedented challenges and threats to patients and healthcare systems worldwide. Acute respiratory complications that require intensive care unit (ICU) management are a major cause of morbidity and mortality in COVID-19 patients. Patients with worst outcomes and higher mortality are reported to include immunocompromised subjects, namely older adults and polymorbid individuals and malnourished people in general. ICU stay, polymorbidity and older age are all commonly associated with high risk for malnutrition, representing per se a relevant risk factor for higher morbidity and mortality in chronic and acute disease. Also importantly, prolonged ICU stays are reported to be required for COVID-19 patients stabilization, and longer ICU stay may per se directly worsen or cause malnutrition, with severe loss of skeletal muscle mass and function which may lead to disability, poor quality of life and additional morbidity. Prevention, diagnosis and treatment of malnutrition should therefore be routinely included in the management of COVID-19 patients. In the current document, the European Society for Clinical Nutrition and Metabolism (ESPEN) aims at providing concise guidance for nutritional management of COVID-19 patients by proposing 10 practical recommendations. The practical guidance is focused to those in the ICU setting or in the presence of older age and polymorbidity, which are independently associated with malnutrition and its negative impact on patient survival."],"journal":"Clin Nutr","authors":["Barazzoni, Rocco","Bischoff, Stephan C","Breda, Joao","Wickramasinghe, Kremlin","Krznaric, Zeljko","Nitzan, Dorit","Pirlich, Matthias","Singer, Pierre"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305181","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.clnu.2020.03.022","topics":["Prevention","Treatment"],"weight":1,"_version_":1666138493392257024,"score":97.15317},{"pmid":32379381,"title":"Widening Disparities Among Patients with Rheumatic Diseases in the COVID-19 Era: An Urgent Call to Action.","text":["Widening Disparities Among Patients with Rheumatic Diseases in the COVID-19 Era: An Urgent Call to Action.","Recent data from multiple public health departments across the U.S. highlighting the disproportionate burden of COVID-19 infections in vulnerable populations serve as an urgent call to action. As rheumatologists, we are acutely aware of the higher morbidity and mortality, and for a number of our diseases, the higher incidence and prevalence among racial/ethnic minorities and individuals of lower socioeconomic status (SES). Comorbidities are frequent, timely access to subspecialty care is limited, receipt of high quality care is less common, and care is more often fragmented with frequent, avoidable acute care use.","Arthritis Rheumatol","Feldman, Candace H","Ramsey-Goldman, Rosalind","32379381"],"abstract":["Recent data from multiple public health departments across the U.S. highlighting the disproportionate burden of COVID-19 infections in vulnerable populations serve as an urgent call to action. As rheumatologists, we are acutely aware of the higher morbidity and mortality, and for a number of our diseases, the higher incidence and prevalence among racial/ethnic minorities and individuals of lower socioeconomic status (SES). Comorbidities are frequent, timely access to subspecialty care is limited, receipt of high quality care is less common, and care is more often fragmented with frequent, avoidable acute care use."],"journal":"Arthritis Rheumatol","authors":["Feldman, Candace H","Ramsey-Goldman, Rosalind"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379381","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/art.41306","locations":["USA"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666262687620792320,"score":95.17197},{"pmid":32400084,"title":"SARS-CoV-2 infection in two patients following recent lung transplantation.","text":["SARS-CoV-2 infection in two patients following recent lung transplantation.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes Coronavirus disease 2019 (COVID-19) has become a world spreading health problem with pandemic character. Lung transplant recipients may be particularly at risk due to the high degree of immunosupression and the lung being the organ primarily affected by COVID-19. We describe a 16-year old male and a 64-year old female recently lung transplanted patients with COVID-19 during inpatient rehabilitation. Both patients were on triple immunosuppressive therapy and had no signs of allograft dysfunction. Both patients had close contact to a person who developed COVID-19 and were tested positive for SARS-CoV-2. Subsequently, both patients underwent systematic screening and SARS-CoV-2 was detected ultimately. While the 16-year old boy was completely asymptomatic, the 64-year old woman developed only mild COVID-19. Immunosuppressive therapy was unchanged and no experimental treatment was initiated. No signs of graft involvement or dysfunction were noticed. In conclusion, our report of patients with asymptomatic SARS-CoV-2 infection and mild COVID-19 respectively, may indicate that lung transplant recipients are not per se at risk for severe COVID-19. Further observations and controlled trials are urgently needed to study SARS-CoV-2 infection in lung transplant recipients.","Am J Transplant","Koczulla, Rembert A","Sczepanski, Bernd","Koteczki, Adam","Kuhnert, Stefan","Hecker, Matthias","Askevold, Ingolf","Schneider, Christian","Michel, Sebastian","Kneidinger, Nikolaus","32400084"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes Coronavirus disease 2019 (COVID-19) has become a world spreading health problem with pandemic character. Lung transplant recipients may be particularly at risk due to the high degree of immunosupression and the lung being the organ primarily affected by COVID-19. We describe a 16-year old male and a 64-year old female recently lung transplanted patients with COVID-19 during inpatient rehabilitation. Both patients were on triple immunosuppressive therapy and had no signs of allograft dysfunction. Both patients had close contact to a person who developed COVID-19 and were tested positive for SARS-CoV-2. Subsequently, both patients underwent systematic screening and SARS-CoV-2 was detected ultimately. While the 16-year old boy was completely asymptomatic, the 64-year old woman developed only mild COVID-19. Immunosuppressive therapy was unchanged and no experimental treatment was initiated. No signs of graft involvement or dysfunction were noticed. In conclusion, our report of patients with asymptomatic SARS-CoV-2 infection and mild COVID-19 respectively, may indicate that lung transplant recipients are not per se at risk for severe COVID-19. Further observations and controlled trials are urgently needed to study SARS-CoV-2 infection in lung transplant recipients."],"journal":"Am J Transplant","authors":["Koczulla, Rembert A","Sczepanski, Bernd","Koteczki, Adam","Kuhnert, Stefan","Hecker, Matthias","Askevold, Ingolf","Schneider, Christian","Michel, Sebastian","Kneidinger, Nikolaus"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32400084","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1111/ajt.15998","topics":["Case Report"],"weight":1,"_version_":1666865855075450880,"score":92.950455}]}